{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:21:55Z","timestamp":1789608115531,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the China National Natural Scientific Fund","award":["81572490"],"award-info":[{"award-number":["81572490"]}]},{"name":"the Tianjin Science and Technology Committee","award":["13JCZDJC31000"],"award-info":[{"award-number":["13JCZDJC31000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00432-017-2415-5","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T03:16:28Z","timestamp":1491880588000},"page":"1477-1487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K\/AKT signaling pathway"],"prefix":"10.1007","volume":"143","author":[{"given":"Yang","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"2415_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PPO.0b013e318244d7eb","volume":"18","author":"KP Becker","year":"2012","unstructured":"Becker KP, Yu J (2012) Status quo-standard-of-care medical and radiation therapy for glioblastoma. Cancer J 18:12\u201319. doi:\n                        10.1097\/PPO.0b013e318244d7eb","journal-title":"Cancer J"},{"key":"2415_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2015.00166","volume":"5","author":"M Berm\u00fadez Brito","year":"2015","unstructured":"Berm\u00fadez Brito M, Goulielmaki E, Papakonstanti EA (2015) Focus on PTEN regulation. Front Oncol 5:166. doi:\n                        10.3389\/fonc.2015.00166","journal-title":"Front Oncol"},{"key":"2415_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/nop059","volume":"12","author":"E Chautard","year":"2010","unstructured":"Chautard E, Loubeau G, Tchirkov A, Chassagne J, Vermot-Desroches C, Morel L, Verrelle P (2010) Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol 12:434\u2013443. doi:\n                        10.1093\/neuonc\/nop059","journal-title":"Neuro Oncol"},{"key":"2415_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1210\/me.2013-1196","volume":"28","author":"GE Dressing","year":"2014","unstructured":"Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA (2014) Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Mol Endocrinol 28:442\u2013457. doi:\n                        10.1210\/me.2013-1196","journal-title":"Mol Endocrinol"},{"key":"2415_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10571-015-0190-x","volume":"35","author":"XY Fu","year":"2015","unstructured":"Fu XY, Zhang S, Wang K, Yang MF, Fan CD, Sun BL (2015) Caudatin inhibits human glioma cells growth through triggering DNA damage-mediated cell cycle arrest. Cell Mol Neurobiol 35:953\u2013959. doi:\n                        10.1007\/s10571-015-0190-x","journal-title":"Cell Mol Neurobiol"},{"key":"2415_CR6","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.18632\/oncotarget.1893","volume":"5","author":"K Gabrusiewicz","year":"2014","unstructured":"Gabrusiewicz K, Liu D, Cortes-Santiago N, Hossain MB, Conrad CA, Aldape KD, Fuller GN, Marini FC, Alonso MM, Idoate MA, Gilbert MR, Fueyo J, Gomez-Manzano C (2014) Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget 5:2208\u20132220. doi:\n                        10.18632\/oncotarget.1893","journal-title":"Oncotarget"},{"key":"2415_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s12032-009-9295-8","volume":"27","author":"L Han","year":"2010","unstructured":"Han L, Zhang AL, Xu P, Yue X, Yang Y, Wang GX, Jia ZF, Pu PY, Kang CS (2010) Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo. Med Oncol 27:843\u2013852. doi:\n                        10.1007\/s12032-009-9295-8","journal-title":"Med Oncol"},{"key":"2415_CR8","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1158\/0008-5472.CAN-06-3398","volume":"67","author":"Z Jiang","year":"2007","unstructured":"Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A (2007) Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Res 67:4467\u20134473. doi:\n                        10.1158\/0008-5472.CAN-06-3398","journal-title":"Cancer Res"},{"key":"2415_CR9","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.18632\/oncotarget.3221","volume":"6","author":"L Jiang","year":"2015","unstructured":"Jiang L, Wang C, Lei F, Zhang LJ, Zhang X, Liu AB, Wu GY, Zhu JR, Song L (2015) miR-93 promotes cell proliferation in gliomas through activation of PI3K\/Akt signaling pathway. Oncotarget 6:8286\u20138299. doi:\n                        10.18632\/oncotarget.3221","journal-title":"Oncotarget"},{"key":"2415_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1078-0432.CCR-05-1084","volume":"12","author":"CM Lee","year":"2006","unstructured":"Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006) Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res 12:250\u2013256. doi:\n                        10.1158\/1078-0432.CCR-05-1084","journal-title":"Clin Cancer Res"},{"key":"2415_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R, Nordic Clinical Brain Tumour Study Group (NCBTSG), for the Nordic Clinical Brain Tumour Study Group (NCBTSG) (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60\u00a0years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916\u2013926. doi:\n                        10.1016\/S1470-2045(12)70265-6","journal-title":"Lancet Oncol"},{"key":"2415_CR12","doi-asserted-by":"publisher","first-page":"41942","DOI":"10.1038\/srep41942","volume":"7","author":"Y Miao","year":"2017","unstructured":"Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L (2017) MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K\/Akt signaling pathway. Sci Rep 7:41942. doi:\n                        10.1038\/srep41942","journal-title":"Sci Rep"},{"key":"2415_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11060-004-1718-y","volume":"71","author":"JL Nakamura","year":"2005","unstructured":"Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA (2005) PKB\/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J Neurooncol 71:215\u2013222. doi:\n                        10.1007\/s11060-004-1718-y","journal-title":"J Neurooncol"},{"key":"2415_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2052-8426-2-21","volume":"2","author":"H Okura","year":"2014","unstructured":"Okura H, Smith CA, Rutka JT (2014) Gene therapy for malignant glioma. Mol Cell Ther 2:21","journal-title":"Mol Cell Ther"},{"key":"2415_CR15","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1158\/0008-5472.CAN-07-6769","volume":"68","author":"D Opel","year":"2008","unstructured":"Opel D, Westhoff MA, Bender A, Braun VD, Debatin KM, Fulda S (2008) Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res 68:6271\u20136280. doi:\n                        10.1158\/0008-5472.CAN-07-6769","journal-title":"Cancer Res"},{"key":"2415_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-005-3029-3","volume":"76","author":"PY Pu","year":"2006","unstructured":"Pu PY, Kang CS, Li J, Jiang H, Cheng JQ (2006) The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 76:1\u201311. doi:\n                        10.1007\/s11060-005-3029-3","journal-title":"J Neurooncol"},{"key":"2415_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2407-10-27","volume":"10","author":"Y Ren","year":"2010","unstructured":"Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, Jia ZF, Xu P, Pu PY, Kang CS (2010) MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to Taxol. BMC Cancer 10:27. doi:\n                        10.1186\/1471-2407-10-27","journal-title":"BMC Cancer"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. doi:\n                        10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"2415_CR19","doi-asserted-by":"publisher","first-page":"87100","DOI":"10.18632\/oncotarget.13527","volume":"7","author":"Y Tan","year":"2016","unstructured":"Tan Y, Huang N, Zhang X, Hu J, Cheng S, Pi L, Cheng Y (2016) KIAA0247 suppresses the proliferation, angiogenesis and promote apoptosis of human glioma through inactivation of the AKT and Stat3 signaling pathway. Oncotarget 7:87100\u201387113. doi:\n                        10.18632\/oncotarget.13527","journal-title":"Oncotarget"},{"key":"2415_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1517\/14728222.2013.733001","volume":"17","author":"S Thomas","year":"2013","unstructured":"Thomas S, Quinn BA, Das SK, Dash R, Emdad L, Dasgupta S, Wang XY, Dent P, Reed JC, Pellecchia M, Sarkar D, Fisher PB (2013) Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets 17:61\u201375. doi:\n                        10.1517\/14728222.2013.733001","journal-title":"Expert Opin Ther Targets"},{"key":"2415_CR21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/neuonc\/not107","volume":"15","author":"XR Wang","year":"2013","unstructured":"Wang XR, Luo H, Li HL, Cao L, Wang XF, Yan W, Wang YY, Zhang JX, Jiang T, Kang CS, Liu N, You YP, Chinese Glioma Cooperative Group (CGCG) (2013) Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN. Neuro Oncol 15:1491\u20131501. doi:\n                        10.1093\/neuonc\/not107","journal-title":"Neuro Oncol"},{"key":"2415_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrneurol.2015.242","volume":"12","author":"PY Wen","year":"2016","unstructured":"Wen PY, Reardon DA (2016) Neuro-oncology in 2015: progress in glioma diagnosis, classification and treatment. Nat Rev Neurol 12:69\u201370. doi:\n                        10.1038\/nrneurol.2015.242","journal-title":"Nat Rev Neurol"},{"key":"2415_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tranon.2016.12.008","volume":"10","author":"YL Wu","year":"2017","unstructured":"Wu YL, Maachani UB, Schweitzer M, Singh R, Wang M, Chang R, Souweidane MM (2017) Dual inhibition of PI3K\/AKT and MEK\/ERK pathways induces synergistic antitumor effects in diffuse intrinsic pontine glioma cells. Transl Oncol 10:221\u2013228. doi:\n                        10.1016\/j.tranon.2016.12.008","journal-title":"Transl Oncol"},{"key":"2415_CR24","doi-asserted-by":"publisher","first-page":"e53654","DOI":"10.1371\/journal.pone.0053654","volume":"8","author":"P Xu","year":"2013","unstructured":"Xu P, Zhang AL, Jiang RC, Qiu MZ, Kang CS, Jia ZF, Wang GX, Han L, Fan X, Pu PY (2013) The different role of Notch1 and Notch2 in astrocytic gliomas. PLoS One 8:e53654. doi:\n                        10.1371\/journal.pone.0053654","journal-title":"PLoS One"},{"key":"2415_CR25","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1007\/s12035-015-9340-x","volume":"53","author":"C Yao","year":"2016","unstructured":"Yao C, Li P, Song H, Song F, Qu Y, Ma X, Shi R, Wu J (2016) CXCL12\/CXCR4 axis upregulates twist to induce EMT in human glioblastoma. Mol Neurobiol 53:3948\u20133953. doi:\n                        10.1007\/s12035-015-9340-x","journal-title":"Mol Neurobiol"},{"key":"2415_CR26","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.22034\/APJCP.2016.17.6203","volume":"17","author":"Y Yazdani","year":"2016","unstructured":"Yazdani Y, Sharifi Rad MR, Taghipour M, Chenari N, Ghaderi A, Razmkhah M (2016) Genistein suppression of matrix metalloproteinase 2 (MMP-2) and vascular endothelial growth factor (VEGF) expression in mesenchymal stem cell like cells isolated from high and low grade gliomas. Asian Pac J Cancer Prev 17:6203\u20136207. doi:\n                        10.22034\/APJCP.2016.17.6203","journal-title":"Asian Pac J Cancer Prev"},{"key":"2415_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1479-5876-10-119","volume":"10","author":"CZ Zhang","year":"2012","unstructured":"Zhang CZ, Zhang JX, Hao JW, Shi ZD, Wang YY, Han L, Yu SZ, You YP, Jiang T, Wang JH, Liu ML, Pu PY, Kang CS (2012) High level of miR-221\/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 10:119. doi:\n                        10.1186\/1479-5876-10-119","journal-title":"J Transl Med"},{"key":"2415_CR28","doi-asserted-by":"publisher","first-page":"23823","DOI":"10.3390\/ijms161023823","volume":"16","author":"FY Zhang","year":"2015","unstructured":"Zhang FY, Hu Y, Que ZY, Wang P, Liu YH, Wang ZH, Xue YX (2015) Shikonin inhibits the migration and invasion of human glioblastoma cells by targeting phosphorylated \u03b2-catenin and phosphorylated PI3K\/Akt: a potential mechanism for the anti-glioma efficacy of a traditional Chinese herbal medicine. Int J Mol Sci 16:23823\u201323848. doi:\n                        10.3390\/ijms161023823","journal-title":"Int J Mol Sci"},{"key":"2415_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/labinvest.2009.126","volume":"90","author":"X Zhou","year":"2010","unstructured":"Zhou X, Ren Y, Moore L, Mei M, You YP, Xu P, Wang BL, Wang GX, Jia ZF, Pu PY, Zhang W, Kang CS (2010) Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90:144\u2013155. doi:\n                        10.1038\/labinvest.2009.126","journal-title":"Lab Invest"},{"key":"2415_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/cam4.987","volume":"6","author":"D Zhu","year":"2017","unstructured":"Zhu D, Tu M, Zeng B, Cai L, Zheng W, Su Z, Yu Z (2017) Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR\/Bcl-2. Cancer Med 6:452\u2013462. doi:\n                        10.1002\/cam4.987","journal-title":"Cancer Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2415-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2415-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T10:04:18Z","timestamp":1499681058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2415-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2415-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]}}}